Ubs Group Ag Novartis Ag Put Options Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

Put Options

22 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$106.13 - $120.89 $3.25 Million - $3.7 Million	-30,600 Reduced 50.5%	30,000 $3.45 Million
Q2 2024 Aug 13, 2024	BUY	$92.57 - $107.37 $5.61 Million - $6.51 Million	60,600 New	60,600 $6.45 Million
Q3 2023 Nov 09, 2023	SELL	$94.73 - $105.13 $4.26 Million - $4.73 Million	-45,000 Reduced 77.19%	13,300 $1.35 Million
Q2 2023 Aug 11, 2023	BUY	$92.52 - $104.91 $5.39 Million - $6.12 Million	58,300 New	58,300 $5.88 Million
Q3 2022 Nov 10, 2022	BUY	$74.61 - $87.26 $82,071 - $95,986	1,100 Added 183.33%	1,700 $129,000
Q2 2022 Aug 10, 2022	SELL	$80.52 - $93.75 $128,832 - $150,000	-1,600 Reduced 72.73%	600 $51,000
Q2 2021 Aug 13, 2021	BUY	$85.24 - $94.15 $68,192 - $75,320	800 Added 57.14%	2,200 $201,000
Q1 2021 May 12, 2021	SELL	$83.5 - $98.47 $108,550 - $128,011	-1,300 Reduced 48.15%	1,400 $120,000
Q4 2020 Feb 11, 2021	BUY	$78.07 - $94.43 $54,648 - $66,101	700 Added 35.0%	2,700 $255,000
Q3 2020 Nov 12, 2020	BUY	$82.14 - $91.0 $123,210 - $136,500	1,500 Added 300.0%	2,000 $174,000
Q1 2020 May 01, 2020	SELL	$70.67 - $99.01 $70,670 - $99,010	-1,000 Reduced 66.67%	500 $41,000
Q3 2019 Nov 14, 2019	SELL	$85.54 - $94.26 $119,756 - $131,964	-1,400 Reduced 48.28%	1,500 $130,000
Q2 2019 Aug 14, 2019	BUY	$75.4 - $92.8 $120,640 - $148,480	1,600 Added 123.08%	2,900 $265,000
Q1 2019 May 14, 2019	SELL	$75.32 - $86.15 $112,979 - $129,225	-1,500 Reduced 53.57%	1,300 $125,000
Q4 2018 Feb 14, 2019	BUY	$73.66 - $82.02 $95,758 - $106,626	1,300 Added 86.67%	2,800 $240,000
Q3 2018 Nov 14, 2018	BUY	$66.94 - $77.43 $66,940 - $77,430	1,000 Added 200.0%	1,500 $129,000
Q2 2018 Aug 14, 2018	SELL	$64.91 - $73.36 $337,532 - $381,472	-5,200 Reduced 91.23%	500 $38,000
Q1 2018 May 15, 2018	BUY	$70.39 - $84.15 $288,599 - $345,015	4,100 Added 256.25%	5,700 $461,000
Q4 2017 Feb 14, 2018	BUY	$72.33 - $77.64 $7,233 - $7,764	100 Added 6.67%	1,600 $134,000
Q3 2017 Nov 14, 2017	SELL	$74.14 - $77.27 $155,694 - $162,267	-2,100 Reduced 58.33%	1,500 $129,000
Q2 2017 Aug 14, 2017	BUY	N/A	2,800 Added 350.0%	3,600 $300,000
Q1 2017 Nov 14, 2017	BUY	N/A	800	800 $59,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $209B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account